BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2256641)

  • 1. [Bone complications from chronic etretinate intoxication in children].
    Cointin M; Sommelet-Olive D; Cuny JF; Bretagne MC
    Ann Pediatr (Paris); 1990 Sep; 37(7):458-60. PubMed ID: 2256641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatologic effects of etretinate].
    Cuny JF; Schmutz JL; Terver MN; Aussedat R; Cointin M; Weber M; Beurey J
    Ann Dermatol Venereol; 1989; 116(2):95-102. PubMed ID: 2660711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital pachyonychia treated by oral retinoid].
    Rondón Lugo AJ
    Med Cutan Ibero Lat Am; 1982; 10(6):395-8. PubMed ID: 6764243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone changes in children on long-term treatment with etretinate.
    Halkier-Sørensen L; Laurberg G; Andresen J
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):999-1006. PubMed ID: 3584585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for skeletal toxicity of children treated with etretinate.
    Glover MT; Peters AM; Atherton DJ
    Br J Dermatol; 1987 May; 116(5):609-14. PubMed ID: 3297126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone changes and their significance in children with ichthyosis on long-term etretinate therapy.
    Paige DG; Judge MR; Shaw DG; Atherton DJ; Harper JI
    Br J Dermatol; 1992 Oct; 127(4):387-91. PubMed ID: 1419759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate (Tigason).
    Wilson DJ; Kay V; Charig M; Hughes DG; Creasy TS
    Br J Dermatol; 1988 Nov; 119(5):597-607. PubMed ID: 3207613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature epiphyseal closure--a complication of etretinate therapy in children.
    Prendiville J; Bingham EA; Burrows D
    J Am Acad Dermatol; 1986 Dec; 15(6):1259-62. PubMed ID: 3805366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etretinate-responsive pachyonychia congenita.
    Carabott F; Archer CB; Griffiths WA
    Br J Dermatol; 1988 Oct; 119(4):551-3. PubMed ID: 3191023
    [No Abstract]   [Full Text] [Related]  

  • 10. Skeletal changes associated with chronic isotretinoin and etretinate administration.
    McGuire J; Lawson JP
    Dermatologica; 1987; 175 Suppl 1():169-81. PubMed ID: 3121403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcifying arthropathy of the hips and diffuse hyperostosis associated with etretinate.
    Cerio R; Wells RS; MacDonald DM
    Clin Exp Dermatol; 1987 Mar; 12(2):129-31. PubMed ID: 3677472
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrospective radiographic study of skeletal changes after long-term etretinate therapy.
    Melnik B; Glück S; Jungblut RM; Goerz G
    Br J Dermatol; 1987 Feb; 116(2):207-12. PubMed ID: 3828215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pachyonychia congenita. Three familial cases. Effects of the treatment by aromatic retinoid (RO 10.9359) (author's transl)].
    Dupré A; Christol B; Bonafé JL; Touron P
    Ann Dermatol Venereol; 1981; 108(2):145-9. PubMed ID: 7247217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of bone changes in adults treated with etretinate.
    Halkier-Sørensen L; Andresen J
    J Am Acad Dermatol; 1989 Jan; 20(1):83-7. PubMed ID: 2913084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etretinate therapy in children with severe keratinization defects.
    Traupe H; Happle R
    Eur J Pediatr; 1985 Jan; 143(3):166-9. PubMed ID: 2580708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate.
    DiGiovanna JJ; Helfgott RK; Gerber LH; Peck GL
    N Engl J Med; 1986 Nov; 315(19):1177-82. PubMed ID: 3463863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etretinate therapy.
    Baran R
    Arch Dermatol; 1984 Aug; 120(8):993. PubMed ID: 6465922
    [No Abstract]   [Full Text] [Related]  

  • 18. Etretinate-induced heterotopic bone formation about the hip joint. A case report including ultrastructural study.
    Inoue K; Imai S; Iwasaki A; Egawa M; Hukuda S
    Clin Orthop Relat Res; 1994 Nov; (308):139-45. PubMed ID: 7955675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical hyperostosis and enthesopathy due to long-term etretinate administration.
    Guit GL; Obermann WR; van der Schroeff JG; Sillevis-Smitt HJ
    Diagn Imaging Clin Med; 1986; 55(4-5):214-8. PubMed ID: 3095013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diffuse idiopathic skeletal hyperostosis (DISH) and pseudo-coxarthritis following long-term etretinate therapy].
    Theiler R; Hübscher E; Wagenhäuser FJ; Panizzon R; Michel B
    Schweiz Med Wochenschr; 1993 Apr; 123(14):649-53. PubMed ID: 8480163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.